Echocardiographic Study of the Haemodynamic Effects of Remifentanil With and Without Glycopyrrolate in Healthy Children

Phase 2

Completed

• Conditions: Urological Surgery

• Registration Number: NCT00315536
• Lead Sponsor: University Hospital, Ghent

Brief Summary

Study to investigate the influence of remifentanil and glycopyrrolate on cardiac index and blood pressure in children.To differentiate between contractility and the effect of the circulating volume, some of the subjects will receive additional fluid.This will be evaluated using two transthoracic echocardiac exams within the first 30 min of anesthesia.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-04-14
• Study First Submitted QC: 2006-04-14
• Study First Posted: 2006-04-18
• Study Start: 2006-05
• Primary Completion: 2009-04
• Study Completion: 2009-04
• Status Verified: 2012-01
• Last Update Submitted: 2012-01-03
• Last Update Posted: 2012-01-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

• ASA I and II children
• 1-6 years
• urological surgery

Exclusion Criteria

• Cardiac disease
• Diabetes

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Cardiac index	Twice in 16 minutes.
Blood pressure	Twice in 16 minutes.

Trial Locations

Locations (1)

University Hospital Ghent; 🇧🇪 Ghent, Belgium